NVCR vs. MRK
Compare and contrast key facts about NovoCure Limited (NVCR) and Merck & Co., Inc. (MRK).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: NVCR or MRK.
Correlation
The correlation between NVCR and MRK is 0.15, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
NVCR vs. MRK - Performance Comparison
Key characteristics
NVCR:
0.18
MRK:
-1.46
NVCR:
1.01
MRK:
-1.97
NVCR:
1.11
MRK:
0.73
NVCR:
0.15
MRK:
-0.95
NVCR:
0.55
MRK:
-1.83
NVCR:
26.09%
MRK:
19.35%
NVCR:
81.10%
MRK:
24.33%
NVCR:
-95.07%
MRK:
-68.62%
NVCR:
-92.69%
MRK:
-37.29%
Fundamentals
NVCR:
$1.81B
MRK:
$205.80B
NVCR:
-$1.56
MRK:
$6.74
NVCR:
-0.47
MRK:
0.79
NVCR:
$466.72M
MRK:
$48.39B
NVCR:
$363.23M
MRK:
$39.64B
NVCR:
-$70.91M
MRK:
$19.98B
Returns By Period
In the year-to-date period, NVCR achieves a -44.66% return, which is significantly lower than MRK's -17.40% return.
NVCR
-44.66%
-18.29%
12.02%
20.01%
-23.97%
N/A
MRK
-17.40%
-13.18%
-24.54%
-34.46%
4.87%
7.29%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
NVCR vs. MRK — Risk-Adjusted Performance Rank
NVCR
MRK
NVCR vs. MRK - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for NovoCure Limited (NVCR) and Merck & Co., Inc. (MRK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
NVCR vs. MRK - Dividend Comparison
NVCR has not paid dividends to shareholders, while MRK's dividend yield for the trailing twelve months is around 3.88%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NVCR NovoCure Limited | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
MRK Merck & Co., Inc. | 3.88% | 3.14% | 2.72% | 2.52% | 3.41% | 3.03% | 2.48% | 2.60% | 3.36% | 3.14% | 3.43% | 3.12% |
Drawdowns
NVCR vs. MRK - Drawdown Comparison
The maximum NVCR drawdown since its inception was -95.07%, which is greater than MRK's maximum drawdown of -68.62%. Use the drawdown chart below to compare losses from any high point for NVCR and MRK. For additional features, visit the drawdowns tool.
Volatility
NVCR vs. MRK - Volatility Comparison
NovoCure Limited (NVCR) has a higher volatility of 14.08% compared to Merck & Co., Inc. (MRK) at 8.87%. This indicates that NVCR's price experiences larger fluctuations and is considered to be riskier than MRK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
NVCR vs. MRK - Financials Comparison
This section allows you to compare key financial metrics between NovoCure Limited and Merck & Co., Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities